CRSP
Price
$37.78
Change
-$1.17 (-3.00%)
Updated
Apr 16 closing price
Capitalization
3.24B
25 days until earnings call
IMNM
Price
$7.28
Change
+$0.11 (+1.53%)
Updated
Apr 17, 10:30 AM (EDT)
Capitalization
623.44M
21 days until earnings call
Ad is loading...

CRSP vs IMNM

Header iconCRSP vs IMNM Comparison
Open Charts CRSP vs IMNMBanner chart's image
CRISPR Therapeutics AG
Price$37.78
Change-$1.17 (-3.00%)
Volume$1.65M
Capitalization3.24B
Immunome
Price$7.28
Change+$0.11 (+1.53%)
Volume$27.43K
Capitalization623.44M
CRSP vs IMNM Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. IMNM commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and IMNM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 17, 2025
Stock price -- (CRSP: $37.78 vs. IMNM: $7.17)
Brand notoriety: CRSP and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 69% vs. IMNM: 105%
Market capitalization -- CRSP: $3.24B vs. IMNM: $623.44M
CRSP [@Biotechnology] is valued at $3.24B. IMNM’s [@Biotechnology] market capitalization is $623.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 5 bearish.
  • IMNM’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а +8.28% price change this week, while IMNM (@Biotechnology) price change was +15.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.60%. For the same industry, the average monthly price growth was -15.75%, and the average quarterly price growth was -25.61%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+2.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.24B) has a higher market cap than IMNM($623M). CRSP YTD gains are higher at: -4.014 vs. IMNM (-32.486). IMNM has higher annual earnings (EBITDA): -151.35M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. IMNM (217M). IMNM has less debt than CRSP: IMNM (4.83M) vs CRSP (224M). CRSP has higher revenues than IMNM: CRSP (35M) vs IMNM (9.04M).
CRSPIMNMCRSP / IMNM
Capitalization3.24B623M520%
EBITDA-447.31M-151.35M296%
Gain YTD-4.014-32.48612%
P/E RatioN/AN/A-
Revenue35M9.04M387%
Total Cash1.9B217M877%
Total Debt224M4.83M4,636%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
70
SEASONALITY SCORE
1..100
33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPIMNM
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 25 days ago
81%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X84033.870000364.875000
+0.44%
Bitcoin cryptocurrency
GME26.25-0.45
-1.69%
GameStop Corp
SPY525.66-11.95
-2.22%
SPDR® S&P 500® ETF
AAPL194.27-7.87
-3.89%
Apple
TSLA241.55-12.56
-4.94%
Tesla

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-3.00%
BEAM - CRSP
71%
Closely correlated
-3.82%
RXRX - CRSP
69%
Closely correlated
-5.67%
NTLA - CRSP
66%
Closely correlated
-6.79%
PRME - CRSP
63%
Loosely correlated
N/A
ABCL - CRSP
62%
Loosely correlated
-1.65%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-3.11%
KYMR - IMNM
55%
Loosely correlated
-1.73%
IDYA - IMNM
53%
Loosely correlated
-4.71%
RXRX - IMNM
53%
Loosely correlated
-5.67%
BEAM - IMNM
52%
Loosely correlated
-3.82%
ERAS - IMNM
50%
Loosely correlated
-1.68%
More